Friday, July 31, 2026

Auto-Pay EV Charging by Simply Plugging In… Push to Introduce PnC

Hyundai Motor Group plans to enhance convenience for EV users by expanding its Plug & Charge network for automatic payment and authentication.

Russia Reportedly Giving Iran Drone Warfare Tactics From Ukraine War

Russia shares drone tactics with Iran, escalating tensions with the U.S.-Israel alliance amid ongoing conflicts in the region.

Military Loyalty vs. Personal Judgment: KMA Graduates Speak Out After Martial Law Fallout

The martial law incident revealed disillusionment among KMA graduates, highlighting challenges in military obedience and personal judgment.

Tag: clinical trials

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

IKS04: The New ADC Candidate for GI Cancer Approved by FDA – What You Need to Know

LigaChemBio's ADC platform technology enters U.S. clinical trials for gastrointestinal cancer, showcasing its competitive edge in the field.

LSK Global PS Expands Beyond Korea, Leverages Data and AI to Build Global CRO Competitiveness

LSK Global PS enhances global competitiveness by expanding from clinical trials to strategic consulting and data-driven services.

Eli Lilly’s Retatrutide: The Revolutionary Triple Hormone Treatment for Obesity – What You Need to Know

Eli Lilly's retatrutide shows promising results in Phase 3 trials, aiming for FDA approval for obesity and related conditions in 2027.

How Hanmi Pharmaceutical’s AI Platform is Revolutionizing Obesity Drug Development in 2026

Hanmi Pharmaceutical leverages AI for drug discovery, developing innovative obesity treatments and advancing to clinical trials.

Exclusive: GC Biopharma Seeks First Phase 2 Trial for Homegrown mRNA Vaccine This Week

GC Biopharma advances to Phase 2 of South Korea's mRNA vaccine program, aiming for late-stage trials after Phase 1 completion.

Kolon Group’s Biotech Bet Faces Uncertainty as October Trial Readout Becomes Critical

Kolon TissueGene's TG-C osteoarthritis treatment failed its first U.S. Phase 3 trial, raising doubts about the biotech's future.

Revolutionary SperoQure: How JNPMEDI is Transforming Osteoarthritis Treatment in 2026

JNPMEDI will support clinical trials for speroQure, a novel cell therapy for osteoarthritis, ensuring a smooth and effective process.

Lunit Joins Global AI Consortium for Next-Gen Drug Development: What This Means for Precision Medicine

Lunit joins an AI consortium to enhance drug development through AI-driven pathology and biomarker analysis, collaborating with global firms.

From Preclinical Development to Licensing: JNPMEDI Aims to Accelerate K-Biotech Growth With AI

JNPMEDI emphasizes the need for Korea's biotech sector to enhance global commercialization and reduce clinical trial costs using AI.

Breakthrough in MASH Treatment: How miRNA-10a Outperforms Resmetirom in Fat Reduction

RXBio's miRNA-10a shows superior efficacy over Resmetirom in treating MASH, reducing fat, fibrosis, and inflammation significantly.

Kangstem Biotech Signs Organoid Technology Evaluation Agreement With Global Top Five Pharmaceutical Company

Kangstem Biotech has signed an agreement with a top pharmaceutical company to evaluate drug candidates using its hair follicle organoid platform.

South Korea Eases Phase 3 Trial Requirements for Biosimilars Following U.S. and EU… Early Data Becomes Key Battleground

South Korea's MFDS eases Phase 3 trial requirements for biosimilars, aligning with global trends, enhancing early comparability importance.

HLB’s Liver Cancer Drug: FDA’s VAI Conclusion Sparks Hope for Approval

HLB's Rivoceranib facility passed FDA inspection, receiving VAI classification, moving towards new liver cancer drug approval.

Penetrium’s Innovative Cancer Drug Enters Phase 2 Trials in the U.S.: What You Need to Know

Penetrium Bioscience is submitting an IND for Penetrium to start Phase 2 cancer trials in the U.S., leveraging prior safety data.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.